

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.06096131 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.61565676 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.44488991 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.42171735 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.30922265 |
| 6 | glutamate secretion (GO:0014047) | 4.29370690 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.09517674 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.00632029 |
| 9 | proline transport (GO:0015824) | 3.89907255 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.87668473 |
| 11 | vocalization behavior (GO:0071625) | 3.71473688 |
| 12 | detection of calcium ion (GO:0005513) | 3.70074575 |
| 13 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.61047254 |
| 14 | exploration behavior (GO:0035640) | 3.58060658 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 3.55961360 |
| 16 | layer formation in cerebral cortex (GO:0021819) | 3.55665102 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52814748 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 3.50817948 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.46367989 |
| 20 | protein localization to synapse (GO:0035418) | 3.44036250 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 3.38516834 |
| 22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.38208774 |
| 23 | positive regulation of actin filament depolymerization (GO:0030836) | 3.35897841 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.35722378 |
| 25 | potassium ion homeostasis (GO:0055075) | 3.34759635 |
| 26 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.30174519 |
| 27 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.30174519 |
| 28 | neurofilament cytoskeleton organization (GO:0060052) | 3.27268187 |
| 29 | sodium ion export (GO:0071436) | 3.23162499 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.22611506 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.21382641 |
| 32 | detection of temperature stimulus (GO:0016048) | 3.18874473 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.15055710 |
| 34 | negative regulation of microtubule polymerization (GO:0031115) | 3.12343706 |
| 35 | neurotransmitter uptake (GO:0001504) | 3.11971860 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.11937631 |
| 37 | glycine transport (GO:0015816) | 3.11750583 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.09441220 |
| 39 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.07754972 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.04853101 |
| 41 | axon cargo transport (GO:0008088) | 3.04541127 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04044558 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.02418018 |
| 44 | neuron recognition (GO:0008038) | 3.01679340 |
| 45 | transferrin transport (GO:0033572) | 3.00017462 |
| 46 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98901230 |
| 47 | dendrite morphogenesis (GO:0048813) | 2.98260546 |
| 48 | membrane depolarization during action potential (GO:0086010) | 2.97091520 |
| 49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97048097 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96980902 |
| 51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.96878001 |
| 52 | transmission of nerve impulse (GO:0019226) | 2.96683822 |
| 53 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.96438616 |
| 54 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.96438616 |
| 55 | vesicle transport along microtubule (GO:0047496) | 2.96139603 |
| 56 | Golgi transport vesicle coating (GO:0048200) | 2.95483918 |
| 57 | COPI coating of Golgi vesicle (GO:0048205) | 2.95483918 |
| 58 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.95090274 |
| 59 | cellular sodium ion homeostasis (GO:0006883) | 2.94417087 |
| 60 | organelle transport along microtubule (GO:0072384) | 2.92448216 |
| 61 | trivalent inorganic cation transport (GO:0072512) | 2.92322078 |
| 62 | ferric iron transport (GO:0015682) | 2.92322078 |
| 63 | neuronal ion channel clustering (GO:0045161) | 2.91881379 |
| 64 | L-amino acid import (GO:0043092) | 2.90529937 |
| 65 | amino acid import (GO:0043090) | 2.90500328 |
| 66 | establishment of mitochondrion localization (GO:0051654) | 2.90460882 |
| 67 | cell migration in hindbrain (GO:0021535) | 2.90341640 |
| 68 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86418573 |
| 69 | cell communication by electrical coupling (GO:0010644) | 2.86226496 |
| 70 | neurotransmitter transport (GO:0006836) | 2.84734591 |
| 71 | neuronal action potential (GO:0019228) | 2.84642383 |
| 72 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.83516774 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 2.83266971 |
| 74 | neuromuscular process controlling posture (GO:0050884) | 2.81138363 |
| 75 | positive regulation of potassium ion transport (GO:0043268) | 2.80630237 |
| 76 | dendritic spine morphogenesis (GO:0060997) | 2.77708045 |
| 77 | regulation of vesicle fusion (GO:0031338) | 2.77676120 |
| 78 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77575994 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 2.77304192 |
| 80 | glutamate receptor signaling pathway (GO:0007215) | 2.75788427 |
| 81 | axonal fasciculation (GO:0007413) | 2.75108124 |
| 82 | neuron-neuron synaptic transmission (GO:0007270) | 2.74926274 |
| 83 | mating behavior (GO:0007617) | 2.74688168 |
| 84 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.74648620 |
| 85 | positive regulation of vesicle fusion (GO:0031340) | 2.72850809 |
| 86 | cell communication involved in cardiac conduction (GO:0086065) | 2.71206812 |
| 87 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.70913825 |
| 88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.69599038 |
| 89 | positive regulation of neurotransmitter transport (GO:0051590) | 2.68536615 |
| 90 | membrane repolarization (GO:0086009) | 2.66364002 |
| 91 | response to gravity (GO:0009629) | 2.66065963 |
| 92 | membrane budding (GO:0006900) | 2.65789768 |
| 93 | axon ensheathment in central nervous system (GO:0032291) | 2.65692575 |
| 94 | central nervous system myelination (GO:0022010) | 2.65692575 |
| 95 | regulation of neurotransmitter secretion (GO:0046928) | 2.64867077 |
| 96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.64733627 |
| 97 | adult walking behavior (GO:0007628) | 2.63621094 |
| 98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.63476691 |
| 99 | response to auditory stimulus (GO:0010996) | 2.62830171 |
| 100 | potassium ion import (GO:0010107) | 2.62800197 |
| 101 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.62381000 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60480102 |
| 103 | regulation of neurotransmitter levels (GO:0001505) | 2.60354873 |
| 104 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.59595710 |
| 105 | membrane depolarization (GO:0051899) | 2.56344979 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.56313488 |
| 107 | regulation of cell communication by electrical coupling (GO:0010649) | 2.56282208 |
| 108 | nerve growth factor signaling pathway (GO:0038180) | 2.56136729 |
| 109 | acidic amino acid transport (GO:0015800) | 2.55119946 |
| 110 | long-term memory (GO:0007616) | 2.55011614 |
| 111 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53546952 |
| 112 | regulation of synaptic plasticity (GO:0048167) | 2.53398381 |
| 113 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.53355239 |
| 114 | negative regulation of axonogenesis (GO:0050771) | 2.53182221 |
| 115 | presynaptic membrane assembly (GO:0097105) | 2.52702957 |
| 116 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.52209315 |
| 117 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.52138361 |
| 118 | mitochondrion transport along microtubule (GO:0047497) | 2.51518130 |
| 119 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51518130 |
| 120 | synapse assembly (GO:0007416) | 2.50490451 |
| 121 | regulation of postsynaptic membrane potential (GO:0060078) | 2.50473991 |
| 122 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.50238031 |
| 123 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.49933496 |
| 124 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.49889067 |
| 125 | positive regulation of membrane potential (GO:0045838) | 2.49684206 |
| 126 | vesicle docking involved in exocytosis (GO:0006904) | 2.49560991 |
| 127 | tricarboxylic acid cycle (GO:0006099) | 2.47731015 |
| 128 | protein maturation by protein folding (GO:0022417) | 2.45685587 |
| 129 | vesicle docking (GO:0048278) | 2.44074095 |
| 130 | peptidyl-cysteine modification (GO:0018198) | 2.41881308 |
| 131 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38992577 |
| 132 | regulation of neurotransmitter transport (GO:0051588) | 2.38655124 |
| 133 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.37624136 |
| 134 | negative regulation of cation channel activity (GO:2001258) | 2.36178128 |
| 135 | cellular copper ion homeostasis (GO:0006878) | 2.34538354 |
| 136 | substantia nigra development (GO:0021762) | 2.33561722 |
| 137 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.33327258 |
| 138 | signal release (GO:0023061) | 2.33044317 |
| 139 | NADH metabolic process (GO:0006734) | 2.32652485 |
| 140 | myelin maintenance (GO:0043217) | 2.31464550 |
| 141 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.30564347 |
| 142 | long-term synaptic potentiation (GO:0060291) | 2.28826256 |
| 143 | regulation of dendritic spine development (GO:0060998) | 2.28398512 |
| 144 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.28367430 |
| 145 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.28367430 |
| 146 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.27517317 |
| 147 | L-glutamate transport (GO:0015813) | 2.26009855 |
| 148 | establishment of synaptic vesicle localization (GO:0097480) | 2.24121938 |
| 149 | synaptic vesicle transport (GO:0048489) | 2.24121938 |
| 150 | cerebellar Purkinje cell layer development (GO:0021680) | 2.21929575 |
| 151 | cardiac conduction (GO:0061337) | 2.20593811 |
| 152 | positive regulation of exocytosis (GO:0045921) | 2.19943154 |
| 153 | response to dietary excess (GO:0002021) | 2.19230736 |
| 154 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.19174108 |
| 155 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.18359123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.55050823 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13593379 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11384423 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88623817 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84184466 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73014801 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73014801 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.64793685 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63086413 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.63051947 |
| 11 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.62403520 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56939867 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55576228 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48932482 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35592231 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.28493398 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25675858 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24579626 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24116423 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18746864 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17740330 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.11117177 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.10654735 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06189215 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03645592 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99733132 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97026318 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91803499 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77289175 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76664238 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71722699 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60182610 |
| 33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.60132218 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57180734 |
| 35 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.56566103 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55011283 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52187594 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49784287 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48409678 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47869939 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44640331 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39655992 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39030068 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38161275 |
| 45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.37290674 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36849439 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35946955 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35136891 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33322446 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31841307 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28777015 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28255133 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27242349 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26539432 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24492544 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23917764 |
| 57 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23293052 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22960927 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20766975 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20318816 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20006086 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18868361 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17686500 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15665849 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12506824 |
| 66 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12419402 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12376140 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11393370 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10356456 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10263462 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09293466 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09288389 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09021213 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08901884 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08637922 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07980573 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07786868 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05406087 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05005844 |
| 80 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.04625836 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04547693 |
| 82 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04422473 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.03193358 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02852570 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01634352 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01258078 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01094914 |
| 88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99945563 |
| 89 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99364847 |
| 90 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.99293681 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98821323 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98801161 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98125600 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98110817 |
| 95 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97961274 |
| 96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97358968 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97100330 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96877010 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95912256 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95549066 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95100610 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94874591 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94488110 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94169720 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94163453 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94001776 |
| 107 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92727485 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92702221 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92678493 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92441235 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.92214705 |
| 112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91822395 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91501543 |
| 114 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91246658 |
| 115 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91185342 |
| 116 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89270858 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89269644 |
| 118 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.89038575 |
| 119 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88539452 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87773433 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87381241 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87205844 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86503918 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86492566 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86290375 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86290375 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86241443 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85944663 |
| 129 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85606063 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84988997 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.84965080 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84708594 |
| 133 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84246763 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83961395 |
| 135 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.83875560 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83685349 |
| 137 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83012983 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.81403665 |
| 139 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80716197 |
| 140 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80550820 |
| 141 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80182587 |
| 142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79722169 |
| 143 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.78652318 |
| 144 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.78388933 |
| 145 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78011832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.97430515 |
| 2 | MP0004270_analgesia | 3.90061247 |
| 3 | MP0003880_abnormal_central_pattern | 3.88153800 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.75637583 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.46653714 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.29014080 |
| 7 | MP0002736_abnormal_nociception_after | 3.20067066 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.01848417 |
| 9 | MP0002733_abnormal_thermal_nociception | 2.81548407 |
| 10 | MP0004858_abnormal_nervous_system | 2.78097758 |
| 11 | MP0009745_abnormal_behavioral_response | 2.69867201 |
| 12 | MP0002064_seizures | 2.68165192 |
| 13 | MP0009046_muscle_twitch | 2.53962882 |
| 14 | MP0001970_abnormal_pain_threshold | 2.53146884 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.52147976 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.51707065 |
| 17 | MP0002272_abnormal_nervous_system | 2.51110619 |
| 18 | MP0003329_amyloid_beta_deposits | 2.48988699 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.36037547 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.19561483 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.17117412 |
| 22 | MP0001486_abnormal_startle_reflex | 2.01563914 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.97619125 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.92846418 |
| 25 | MP0000920_abnormal_myelination | 1.90913245 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.90197033 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.81172436 |
| 28 | MP0000751_myopathy | 1.75220228 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.73574625 |
| 30 | MP0002184_abnormal_innervation | 1.72831626 |
| 31 | MP0000778_abnormal_nervous_system | 1.72509185 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.71062524 |
| 33 | MP0008569_lethality_at_weaning | 1.69459076 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.68930661 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.64946104 |
| 36 | MP0004924_abnormal_behavior | 1.64946104 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.63552593 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.62492445 |
| 39 | MP0000955_abnormal_spinal_cord | 1.58804926 |
| 40 | MP0002822_catalepsy | 1.55755603 |
| 41 | MP0001905_abnormal_dopamine_level | 1.46393169 |
| 42 | MP0003011_delayed_dark_adaptation | 1.44053022 |
| 43 | MP0003634_abnormal_glial_cell | 1.41262785 |
| 44 | MP0003690_abnormal_glial_cell | 1.40378217 |
| 45 | MP0001529_abnormal_vocalization | 1.37808390 |
| 46 | MP0003633_abnormal_nervous_system | 1.37397810 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.37133623 |
| 48 | MP0005165_increased_susceptibility_to | 1.34937277 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.34732959 |
| 50 | MP0004885_abnormal_endolymph | 1.34702654 |
| 51 | MP0004043_abnormal_pH_regulation | 1.32722822 |
| 52 | MP0002254_reproductive_system_inflammat | 1.30245993 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.29574944 |
| 54 | MP0000604_amyloidosis | 1.28900276 |
| 55 | MP0004142_abnormal_muscle_tone | 1.28662187 |
| 56 | MP0004147_increased_porphyrin_level | 1.28033724 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.27523175 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.23477515 |
| 59 | MP0001756_abnormal_urination | 1.21374364 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.20363846 |
| 61 | MP0001346_abnormal_lacrimal_gland | 1.18015581 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.15943510 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.15833845 |
| 64 | MP0003631_nervous_system_phenotype | 1.15668333 |
| 65 | MP0001765_abnormal_ion_homeostasis | 1.15475054 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.14211551 |
| 67 | MP0000747_muscle_weakness | 1.14169423 |
| 68 | MP0002229_neurodegeneration | 1.14148627 |
| 69 | MP0004130_abnormal_muscle_cell | 1.11996635 |
| 70 | MP0001299_abnormal_eye_distance/ | 1.10149568 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.08366981 |
| 72 | MP0003195_calcinosis | 1.07613011 |
| 73 | MP0005332_abnormal_amino_acid | 1.05772117 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.04150225 |
| 75 | MP0004742_abnormal_vestibular_system | 1.03220708 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.02443163 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.02013825 |
| 78 | MP0003879_abnormal_hair_cell | 0.99738558 |
| 79 | MP0000427_abnormal_hair_cycle | 0.99622669 |
| 80 | MP0005365_abnormal_bile_salt | 0.99464443 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.99288404 |
| 82 | MP0005535_abnormal_body_temperature | 0.98445852 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.98099301 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.94059049 |
| 85 | MP0003122_maternal_imprinting | 0.91981098 |
| 86 | MP0005166_decreased_susceptibility_to | 0.91836456 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.91100869 |
| 88 | MP0000749_muscle_degeneration | 0.90978675 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.89836149 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.88969379 |
| 91 | MP0004085_abnormal_heartbeat | 0.88871133 |
| 92 | MP0001984_abnormal_olfaction | 0.88287062 |
| 93 | MP0003632_abnormal_nervous_system | 0.86934272 |
| 94 | MP0010678_abnormal_skin_adnexa | 0.86719493 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.86682270 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.86261882 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.85694283 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84498297 |
| 99 | MP0002090_abnormal_vision | 0.83648481 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.83033200 |
| 101 | MP0008874_decreased_physiological_sensi | 0.81330936 |
| 102 | MP0002152_abnormal_brain_morphology | 0.79726262 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79410482 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.77662153 |
| 105 | MP0004484_altered_response_of | 0.77010911 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.75984696 |
| 107 | MP0002972_abnormal_cardiac_muscle | 0.75858971 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.75465570 |
| 109 | MP0004233_abnormal_muscle_weight | 0.75283316 |
| 110 | MP0001664_abnormal_digestion | 0.74691998 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.73920903 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.73541703 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.73484071 |
| 114 | MP0003646_muscle_fatigue | 0.73314347 |
| 115 | MP0004510_myositis | 0.72155040 |
| 116 | MP0006082_CNS_inflammation | 0.70334065 |
| 117 | MP0005253_abnormal_eye_physiology | 0.70187598 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.69844769 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.69831734 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.68611205 |
| 121 | MP0003075_altered_response_to | 0.68471499 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.67031953 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.65203042 |
| 124 | MP0001177_atelectasis | 0.64717426 |
| 125 | MP0008872_abnormal_physiological_respon | 0.61385859 |
| 126 | MP0002751_abnormal_autonomic_nervous | 0.59445672 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.58055291 |
| 128 | MP0005171_absent_coat_pigmentation | 0.57424658 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.56252826 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.55459833 |
| 131 | MP0001485_abnormal_pinna_reflex | 0.54351161 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.53404764 |
| 133 | MP0005083_abnormal_biliary_tract | 0.53148188 |
| 134 | MP0003045_fibrosis | 0.51537507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.98883358 |
| 2 | Focal motor seizures (HP:0011153) | 4.84119505 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 4.47419060 |
| 4 | Focal seizures (HP:0007359) | 4.31876502 |
| 5 | Pheochromocytoma (HP:0002666) | 4.16252124 |
| 6 | Visual hallucinations (HP:0002367) | 4.11685016 |
| 7 | Action tremor (HP:0002345) | 4.08308397 |
| 8 | Atonic seizures (HP:0010819) | 3.82970797 |
| 9 | Termporal pattern (HP:0011008) | 3.77926866 |
| 10 | Insidious onset (HP:0003587) | 3.77926866 |
| 11 | Ankle clonus (HP:0011448) | 3.77199157 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 3.74484895 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.68254224 |
| 14 | Ulnar claw (HP:0001178) | 3.32942019 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.16963873 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.13216968 |
| 17 | Absence seizures (HP:0002121) | 3.11138832 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 3.06945752 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.04308359 |
| 20 | Limb dystonia (HP:0002451) | 3.01588006 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 2.94010255 |
| 22 | Mutism (HP:0002300) | 2.92962373 |
| 23 | Dialeptic seizures (HP:0011146) | 2.89421846 |
| 24 | Hypokinesia (HP:0002375) | 2.89005075 |
| 25 | Spastic gait (HP:0002064) | 2.85775872 |
| 26 | Diminished movement (HP:0002374) | 2.84000135 |
| 27 | Papilledema (HP:0001085) | 2.83632971 |
| 28 | Abnormal eating behavior (HP:0100738) | 2.83488216 |
| 29 | Akinesia (HP:0002304) | 2.80851065 |
| 30 | Urinary urgency (HP:0000012) | 2.72638648 |
| 31 | Progressive inability to walk (HP:0002505) | 2.68276360 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.67418084 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67418084 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.67418084 |
| 35 | Increased circulating renin level (HP:0000848) | 2.67323482 |
| 36 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64152946 |
| 37 | Dysmetria (HP:0001310) | 2.62532694 |
| 38 | Febrile seizures (HP:0002373) | 2.61386812 |
| 39 | Tetraplegia (HP:0002445) | 2.61245309 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.61009416 |
| 41 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.61009416 |
| 42 | Depression (HP:0000716) | 2.59900763 |
| 43 | Onion bulb formation (HP:0003383) | 2.59222766 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.56705980 |
| 45 | Anxiety (HP:0000739) | 2.54705888 |
| 46 | Truncal ataxia (HP:0002078) | 2.52195593 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.47562745 |
| 48 | Hammertoe (HP:0001765) | 2.45273215 |
| 49 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.45022372 |
| 50 | Lower limb muscle weakness (HP:0007340) | 2.42905964 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.40246765 |
| 52 | Apathy (HP:0000741) | 2.39043042 |
| 53 | Myotonia (HP:0002486) | 2.36958209 |
| 54 | Delusions (HP:0000746) | 2.36732177 |
| 55 | Foot dorsiflexor weakness (HP:0009027) | 2.35063788 |
| 56 | Rapidly progressive (HP:0003678) | 2.34373469 |
| 57 | Torticollis (HP:0000473) | 2.33600789 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.31840644 |
| 59 | Megalencephaly (HP:0001355) | 2.30351244 |
| 60 | Postural instability (HP:0002172) | 2.30027032 |
| 61 | Hypoglycemic coma (HP:0001325) | 2.29957576 |
| 62 | Polyphagia (HP:0002591) | 2.29895319 |
| 63 | Intention tremor (HP:0002080) | 2.29171697 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.26725085 |
| 65 | Ketoacidosis (HP:0001993) | 2.25333732 |
| 66 | Hypercortisolism (HP:0001578) | 2.23541224 |
| 67 | Diminished motivation (HP:0000745) | 2.23111307 |
| 68 | Steppage gait (HP:0003376) | 2.22728806 |
| 69 | Hemiparesis (HP:0001269) | 2.21304211 |
| 70 | Retinal dysplasia (HP:0007973) | 2.21104819 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.19969124 |
| 72 | Syncope (HP:0001279) | 2.19370525 |
| 73 | Scanning speech (HP:0002168) | 2.15621514 |
| 74 | Poor eye contact (HP:0000817) | 2.15020746 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.14780388 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.14674773 |
| 77 | Cerebral hemorrhage (HP:0001342) | 2.14345596 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 2.12163922 |
| 79 | Abnormality of the foot musculature (HP:0001436) | 2.11289827 |
| 80 | Broad-based gait (HP:0002136) | 2.11060458 |
| 81 | Axonal loss (HP:0003447) | 2.07620511 |
| 82 | Abnormality of pain sensation (HP:0010832) | 2.07029239 |
| 83 | Impaired pain sensation (HP:0007328) | 2.07029239 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.06247343 |
| 85 | Hypoventilation (HP:0002791) | 2.05371713 |
| 86 | Progressive macrocephaly (HP:0004481) | 2.05271811 |
| 87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.05236561 |
| 88 | Hypoplasia of the brainstem (HP:0002365) | 2.05236561 |
| 89 | Abnormal social behavior (HP:0012433) | 2.04740266 |
| 90 | Impaired social interactions (HP:0000735) | 2.04740266 |
| 91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.02686323 |
| 92 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.02686323 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02289449 |
| 94 | Epileptiform EEG discharges (HP:0011182) | 2.01522467 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.01148334 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 2.00204053 |
| 97 | Sudden death (HP:0001699) | 2.00049990 |
| 98 | Amblyopia (HP:0000646) | 1.99968119 |
| 99 | Distal sensory impairment (HP:0002936) | 1.99426120 |
| 100 | Dysdiadochokinesis (HP:0002075) | 1.99226240 |
| 101 | Hypoglycemic seizures (HP:0002173) | 1.99187295 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 1.99109859 |
| 103 | Heart block (HP:0012722) | 1.98864113 |
| 104 | Focal dystonia (HP:0004373) | 1.98496915 |
| 105 | Diplopia (HP:0000651) | 1.97416985 |
| 106 | Abnormality of binocular vision (HP:0011514) | 1.97416985 |
| 107 | Postural tremor (HP:0002174) | 1.96546117 |
| 108 | Resting tremor (HP:0002322) | 1.95494090 |
| 109 | Craniofacial dystonia (HP:0012179) | 1.95313035 |
| 110 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94642670 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 1.93960363 |
| 112 | Abnormality of glycolysis (HP:0004366) | 1.93663115 |
| 113 | Sensory axonal neuropathy (HP:0003390) | 1.93532578 |
| 114 | Tongue fasciculations (HP:0001308) | 1.93179305 |
| 115 | Prolonged QT interval (HP:0001657) | 1.92230349 |
| 116 | Agitation (HP:0000713) | 1.90795056 |
| 117 | Growth hormone excess (HP:0000845) | 1.90549636 |
| 118 | Vascular calcification (HP:0004934) | 1.89777081 |
| 119 | Clonus (HP:0002169) | 1.88767049 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87637376 |
| 121 | Metaphyseal dysplasia (HP:0100255) | 1.87305613 |
| 122 | Mitral stenosis (HP:0001718) | 1.87168046 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 1.87029589 |
| 124 | Rigidity (HP:0002063) | 1.86870947 |
| 125 | Conjunctival hamartoma (HP:0100780) | 1.86812441 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 1.86231386 |
| 127 | Ventricular arrhythmia (HP:0004308) | 1.85494496 |
| 128 | Hemiplegia (HP:0002301) | 1.85381498 |
| 129 | Abnormality of the vocal cords (HP:0008777) | 1.85361146 |
| 130 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84628206 |
| 131 | Nuclear cataract (HP:0100018) | 1.84396808 |
| 132 | Exercise-induced myalgia (HP:0003738) | 1.84132186 |
| 133 | Bundle branch block (HP:0011710) | 1.83664663 |
| 134 | Goiter (HP:0000853) | 1.83564786 |
| 135 | Gaze-evoked nystagmus (HP:0000640) | 1.82244871 |
| 136 | Psychosis (HP:0000709) | 1.81497277 |
| 137 | Slow progression (HP:0003677) | 1.80922944 |
| 138 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.80753335 |
| 139 | Glucose intolerance (HP:0000833) | 1.80592933 |
| 140 | Tetraparesis (HP:0002273) | 1.80410535 |
| 141 | Inability to walk (HP:0002540) | 1.80256537 |
| 142 | Type II lissencephaly (HP:0007260) | 1.79733165 |
| 143 | Increased variability in muscle fiber diameter (HP:0003557) | 1.79573198 |
| 144 | Autoamputation (HP:0001218) | 1.79023498 |
| 145 | Distal lower limb muscle weakness (HP:0009053) | 1.78022617 |
| 146 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77103543 |
| 147 | Testicular atrophy (HP:0000029) | 1.77000571 |
| 148 | Difficulty running (HP:0009046) | 1.76728813 |
| 149 | Bradykinesia (HP:0002067) | 1.76176359 |
| 150 | Hypokalemic alkalosis (HP:0001949) | 1.76166749 |
| 151 | Steatorrhea (HP:0002570) | 1.75566213 |
| 152 | Mucopolysacchariduria (HP:0008155) | 1.74146828 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74146828 |
| 154 | Increased serum pyruvate (HP:0003542) | 1.73890576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.62777656 |
| 2 | NTRK3 | 3.42501055 |
| 3 | MARK1 | 3.15242263 |
| 4 | NTRK1 | 2.96273503 |
| 5 | MINK1 | 2.86042641 |
| 6 | KSR2 | 2.53384484 |
| 7 | LMTK2 | 2.26412042 |
| 8 | PHKG1 | 2.22725772 |
| 9 | PHKG2 | 2.22725772 |
| 10 | PAK6 | 2.20750270 |
| 11 | MAP3K4 | 2.14613781 |
| 12 | STK39 | 2.05247223 |
| 13 | EPHA4 | 2.03046026 |
| 14 | LIMK1 | 1.97384922 |
| 15 | MST4 | 1.93658674 |
| 16 | MAP2K7 | 1.76644363 |
| 17 | MAP3K12 | 1.74838289 |
| 18 | MYLK | 1.72789825 |
| 19 | MAP3K2 | 1.68501907 |
| 20 | ARAF | 1.60598833 |
| 21 | DAPK2 | 1.59497883 |
| 22 | NTRK2 | 1.58542389 |
| 23 | GRK5 | 1.54495484 |
| 24 | PDK2 | 1.50194504 |
| 25 | TNIK | 1.50084555 |
| 26 | BMPR2 | 1.49138301 |
| 27 | CAMKK1 | 1.46989392 |
| 28 | TRIM28 | 1.46476383 |
| 29 | ERBB3 | 1.46242961 |
| 30 | CDK5 | 1.46027815 |
| 31 | PRKD3 | 1.45629391 |
| 32 | MAP2K4 | 1.44890228 |
| 33 | NEK6 | 1.44780273 |
| 34 | LATS2 | 1.44011831 |
| 35 | UHMK1 | 1.41549844 |
| 36 | RIPK4 | 1.40084325 |
| 37 | MAPK13 | 1.39236913 |
| 38 | EIF2AK1 | 1.37888535 |
| 39 | RET | 1.37686319 |
| 40 | MAPKAPK3 | 1.36759110 |
| 41 | OXSR1 | 1.31480207 |
| 42 | CAMKK2 | 1.29319221 |
| 43 | CASK | 1.23573759 |
| 44 | WNK4 | 1.21568851 |
| 45 | SIK3 | 1.20517241 |
| 46 | NEK1 | 1.15296294 |
| 47 | EPHA2 | 1.14350474 |
| 48 | CDK19 | 1.14117817 |
| 49 | TESK2 | 1.12484749 |
| 50 | CDK14 | 1.07763473 |
| 51 | RIPK1 | 1.07075342 |
| 52 | WNK1 | 1.06580680 |
| 53 | PAK3 | 1.04774565 |
| 54 | CSNK1G2 | 1.01736663 |
| 55 | PLK2 | 0.96811778 |
| 56 | CAMK2A | 0.96293301 |
| 57 | MST1R | 0.95883076 |
| 58 | PRPF4B | 0.92515029 |
| 59 | CDK18 | 0.90244725 |
| 60 | CDK15 | 0.90156064 |
| 61 | PRKCG | 0.89986312 |
| 62 | KSR1 | 0.88845387 |
| 63 | TYRO3 | 0.87497109 |
| 64 | FES | 0.86364263 |
| 65 | PKN1 | 0.86042016 |
| 66 | ROCK2 | 0.85193751 |
| 67 | SCYL2 | 0.83681384 |
| 68 | PRKCH | 0.82736308 |
| 69 | SGK223 | 0.81870500 |
| 70 | SGK494 | 0.81870500 |
| 71 | PIK3CA | 0.79454623 |
| 72 | EPHB1 | 0.79447250 |
| 73 | MAP3K1 | 0.79050748 |
| 74 | MAP2K1 | 0.78510747 |
| 75 | PDPK1 | 0.77621637 |
| 76 | CDK11A | 0.77128174 |
| 77 | PAK4 | 0.75599001 |
| 78 | CAMK2D | 0.75206268 |
| 79 | CAMK2B | 0.73809028 |
| 80 | PRKCE | 0.71612286 |
| 81 | BCR | 0.71464875 |
| 82 | MAPKAPK5 | 0.71248050 |
| 83 | CSNK1G3 | 0.70847730 |
| 84 | DMPK | 0.69422001 |
| 85 | PIM2 | 0.68239679 |
| 86 | PNCK | 0.67620087 |
| 87 | FER | 0.67056152 |
| 88 | EIF2AK3 | 0.67029345 |
| 89 | JAK1 | 0.66769201 |
| 90 | PTK2 | 0.66008387 |
| 91 | PDK1 | 0.65712078 |
| 92 | TAOK1 | 0.64760133 |
| 93 | WNK3 | 0.63080010 |
| 94 | PTK2B | 0.61341895 |
| 95 | CAMK2G | 0.61100083 |
| 96 | PINK1 | 0.58572075 |
| 97 | ROCK1 | 0.58124134 |
| 98 | STK38 | 0.57471073 |
| 99 | FYN | 0.55107027 |
| 100 | ABL2 | 0.54702183 |
| 101 | STK11 | 0.53815136 |
| 102 | CSNK1G1 | 0.52873256 |
| 103 | RPS6KA2 | 0.52528232 |
| 104 | DYRK2 | 0.52210572 |
| 105 | TRIB3 | 0.51934009 |
| 106 | CAMK1 | 0.51425772 |
| 107 | MARK2 | 0.51425056 |
| 108 | PRKCZ | 0.49793759 |
| 109 | FGR | 0.49639702 |
| 110 | MAPK12 | 0.48491871 |
| 111 | TSSK6 | 0.48349042 |
| 112 | CAMK1G | 0.48249356 |
| 113 | GRK7 | 0.48045562 |
| 114 | MAP3K13 | 0.47482818 |
| 115 | DAPK1 | 0.47404409 |
| 116 | ILK | 0.46454917 |
| 117 | RAF1 | 0.46310008 |
| 118 | DAPK3 | 0.46242600 |
| 119 | TESK1 | 0.46072357 |
| 120 | FRK | 0.45523484 |
| 121 | TRPM7 | 0.44509834 |
| 122 | PRKG2 | 0.43653923 |
| 123 | PRKD1 | 0.43383433 |
| 124 | ALK | 0.42113714 |
| 125 | STK38L | 0.41905157 |
| 126 | BRSK1 | 0.41646804 |
| 127 | FGFR2 | 0.41597874 |
| 128 | CSNK1A1L | 0.41507415 |
| 129 | MAP2K6 | 0.40457713 |
| 130 | PRKCA | 0.39178317 |
| 131 | ADRBK1 | 0.38747817 |
| 132 | MUSK | 0.38603486 |
| 133 | MATK | 0.38150078 |
| 134 | SIK2 | 0.38100058 |
| 135 | CCNB1 | 0.36917973 |
| 136 | MET | 0.36620313 |
| 137 | PRKCI | 0.36423955 |
| 138 | OBSCN | 0.36373130 |
| 139 | CSNK1A1 | 0.35309160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.07952999 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.38202743 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.32160354 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.08405050 |
| 5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.06975190 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.00835375 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.00439765 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99950365 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94343340 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92868253 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90142291 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86129524 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.81759462 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.73875645 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73323972 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66801366 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66246228 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.65045030 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64420575 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59102095 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54524626 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49574150 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48592678 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44079215 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.42298608 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41348770 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.39455982 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38700377 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38084210 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.35699898 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35096116 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.35050314 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.34866715 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34133761 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32360532 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31955427 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.30103135 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28840051 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28830724 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.25717902 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24790773 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24183262 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23790695 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.23358079 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23122173 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21681243 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21486883 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18001271 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16421850 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.14446068 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13968772 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11902069 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11079245 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08747918 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08283585 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07367977 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05658374 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03212852 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00832050 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99009380 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97819826 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.97536947 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.97129675 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96937195 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96548169 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.96323160 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95809857 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95239693 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93091692 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93024775 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92842572 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92006370 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88418415 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88099286 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84551244 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83706199 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82378800 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82005553 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.81686724 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80895801 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80796084 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.80612865 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79042404 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78558379 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78247347 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76379011 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75047464 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73230027 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72134404 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71705667 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71421003 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70938024 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69529851 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68971424 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.67948264 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67811856 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.67572560 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66755986 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65010415 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64044125 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63568821 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62961874 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.62882696 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60680837 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59911038 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59888393 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59340922 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58986487 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57593791 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57205395 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56956464 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56341121 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56286821 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55125415 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54323427 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53877970 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52758684 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52581651 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51960876 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.51830286 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.51330227 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51181063 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51160751 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49926996 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48338445 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48132463 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46657635 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44576778 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43971004 |
| 130 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43680132 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42640526 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41447037 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40399700 |
| 134 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40332225 |
| 135 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40168368 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.39659184 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38928753 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38597326 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38584353 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38491944 |
| 141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36294995 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36180859 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35819952 |
| 144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35445021 |

